NFKB1 and neoplasm: In addition, PPTLS-APE1/Ref-1 remarkably inhibited inflammatory signaling in tumor tissues by suppressing PAK1–STAT3/NF-κB signaling, accompanied by the downregulation of inflammatory cytokines in the TME.